Stocks · NASDAQ · Healthcare · United States
BIIB — Biogen Inc.
Biogen Inc. (BIIB) is a healthcare stock listed on NASDAQ (United States). At the close of September 29, 2026 it traded at 227.07 (-0.71% on the day), +4.8% over one month, +8.3% over three months, +63.9% over twelve months. The InvestMuse composite score is +17 on a −100 to +100 scale, a mixed read that ranks #544 of about 1,221 assets. The strongest of its nine dimensions are Fundamentals (+53) and Trend (+51); the weakest is Sector edge (-25). Its volatility regime from the hidden Markov model is Calm. 81 news articles in the last 30 days carried an average tone of +0.23 (on −1 to +1).
The facts
| Last close | 227.07 (September 29, 2026) |
|---|---|
| 1 day / 1 month / 3 months / 12 months | -0.71% / +4.8% / +8.3% / +63.9% |
| 52-week range | 138.52 – 228.69 |
| Composite score | +17 / 100 · mixed view · rank #544 |
| Volatility regime (HMM) | Calm |
| Support levels | 140.00, 210.00, 310.00 |
| Trailing P/E | 38.5 |
| Market cap | $32.1B |
The nine dimensions
Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.
- Regime (hidden Markov model)0
- Technical indicators-24
- Trend+51
- Support / resistance0
- Fundamentals+53
- Sector edge-25
- News sentiment+25
- Momentum+24
- Chart patterns and zones-5
How this read is made
Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.
Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.